EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis

Raoul Kenfack-Momo, Marceline Djuidje Ngounoue, Sebastien Kenmoe iD, Guy Roussel Takuissu, Jean Thierry Ebogo-Belobo iD, Cyprien Kengne-Ndé, Donatien Serge Mbaga, Elisabeth Zeuko'o Menkem, Robertine Lontuo Fogang, Serges Tchatchouang, Juliette Laure Ndzie Ondigui, Ginette Irma Kame-Ngasse und 7 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0284169 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, 2024. Verfasst von Raoul Kenfack-Momo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon. Hauptthemen laut MEDLINE: Renal Dialysis, Hepatitis C, Hepacivirus, Kidney Failure, Chronic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dialysis is a replacement therapy for patients with End-Stage Renal Disease (ESRD). Patients on dialysis are at high risk of acquiring hepatitis C virus (HCV), which has become a leading cause of morbidity and mortality in this population. There is a wide range of prevalence of HCV in dialysis populations around the world. It is still unknown how prevalent HCV infection is among worldwide dialysis patients (including those undergoing hemodialysis and peritoneal dialysis). A review was conducted to estimate the global epidemiology of hepatitis C in dialysis patients. We searched PubMed, Excerpta Medica Database (Embase), Global Index Medicus and Web of Science until October 2022. A manual search of references from relevant articles was also conducted. Heterogeneity was evaluated by the χ 2 test on Cochrane’s Q statistic, and the sources of heterogeneity were investigated using subgroup analysis. In order to assess publication bias, funnel plots and Egger tests were conducted, and pooled HCV prevalence estimates were generated using a DerSimonian and Laird meta-analysis model. The study is registered with PROSPERO under CRD42022237789. We included 634 papers involving 392160 participants. The overall HCV case fatality rate was 38.7% (95% CI = 28.9–49). The global prevalence of HCV infection in dialysis population group were 24.3% [95% CI = 22.6–25.9]. As indicated by UNSD region, country, dialysis type, and HCV diagnostic targeted; Eastern Europe had the highest prevalence of 48.6% [95% CI = 35.2–62], Indonesia had 63.6% [95% CI = 42.9–82], hemodialysis patients had 25.5% [95% CI = 23.8–27.3], and anti-HCV were detected in 24.5% [95% CI = 22.8–26.2]. Dialysis patients, particularly those on hemodialysis, have a high prevalence and case fatality rate of HCV infection. Hemodialysis units need to implement strict infection control measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisHepatitis CHepacivirusKidney Failure, ChronicHumansPrevalenceGlobal Health

Autor:innen und Institutionen

  • Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon.
  • Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.
  • Centre for Food, Food Security and Nutrition Research, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
  • Medical Research Centre, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon.
  • Epidemiological Surveillance, Evaluation and Research Unit, National AIDS Control Committee, Douala, Cameroon.
  • Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon.

ORCID-Profile: Sebastien Kenmoe, Jean Thierry Ebogo-Belobo

Förderung

  • European Union

Zitieren

APA

Kenfack-Momo, R., Ngounoue, M. D., Kenmoe, S., Takuissu, G. R., Ebogo-Belobo, J. T., Kengne-Ndé, C., Mbaga, D. S., Zeuko'o Menkem, E., Lontuo Fogang, R., Tchatchouang, S., Ndzie Ondigui, J. L., Kame-Ngasse, G. I., Kenfack-Zanguim, J., Magoudjou-Pekam, J. N., Bowo-Ngandji, A., Mahamat, M., Nkie Esemu, S., Ndip, L., & Njouom, R. (2024). Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0284169

Vancouver

Kenfack-Momo R, Ngounoue MD, Kenmoe S, Takuissu GR, Ebogo-Belobo JT, Kengne-Ndé C, et al. Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0284169

BibTeX
@article{KenfackMomo2024,
  author = {Kenfack-Momo, Raoul and Ngounoue, Marceline Djuidje and Kenmoe, Sebastien and Takuissu, Guy Roussel and Ebogo-Belobo, Jean Thierry and Kengne-Ndé, Cyprien and Mbaga, Donatien Serge and Zeuko'o Menkem, Elisabeth and Lontuo Fogang, Robertine and Tchatchouang, Serges and Ndzie Ondigui, Juliette Laure and Kame-Ngasse, Ginette Irma and Kenfack-Zanguim, Josiane and Magoudjou-Pekam, Jeannette Nina and Bowo-Ngandji, Arnol and Mahamat, Maimouna and Nkie Esemu, Seraphine and Ndip, Lucy and Njouom, Richard},
  title = {Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0284169}
}
Kostenlos starten →